195 related articles for article (PubMed ID: 38266642)
1. Targeted therapy improves cellular dysfunction, ataxia, and seizure susceptibility in a model of a progressive myoclonus epilepsy.
Feng H; Clatot J; Kaneko K; Flores-Mendez M; Wengert ER; Koutcher C; Hoddeson E; Lopez E; Lee D; Arias L; Liang Q; Zhang X; Somarowthu A; Covarrubias M; Gunthorpe MJ; Large CH; Akizu N; Goldberg EM
Cell Rep Med; 2024 Feb; 5(2):101389. PubMed ID: 38266642
[TBL] [Abstract][Full Text] [Related]
2. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK) is caused by heterozygous KCNC1 mutations.
Nascimento FA; Andrade DM
Epileptic Disord; 2016 Sep; 18(S2):135-138. PubMed ID: 27629860
[TBL] [Abstract][Full Text] [Related]
3. Progressive myoclonus epilepsy KCNC1 variant causes a developmental dendritopathy.
Carpenter JC; Männikkö R; Heffner C; Heneine J; Sampedro-Castañeda M; Lignani G; Schorge S
Epilepsia; 2021 May; 62(5):1256-1267. PubMed ID: 33735526
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological rescue of mutated K
Munch AS; Saljic A; Boddum K; Grunnet M; Hougaard C; Jespersen T
Eur J Pharmacol; 2018 Aug; 833():255-262. PubMed ID: 29894724
[TBL] [Abstract][Full Text] [Related]
5. A KCNC1-related neurological disorder due to gain of Kv3.1 function.
Clatot J; Ginn N; Costain G; Goldberg EM
Ann Clin Transl Neurol; 2023 Jan; 10(1):111-117. PubMed ID: 36419348
[TBL] [Abstract][Full Text] [Related]
6. Familial cases of progressive myoclonic epilepsy caused by maternal somatic mosaicism of a recurrent KCNC1 p.Arg320His mutation.
Kim H; Lee S; Choi M; Kim H; Hwang H; Choi J; Chae JH; Kim KJ; Lim BC
Brain Dev; 2018 May; 40(5):429-432. PubMed ID: 29428275
[TBL] [Abstract][Full Text] [Related]
7. A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.
Muona M; Berkovic SF; Dibbens LM; Oliver KL; Maljevic S; Bayly MA; Joensuu T; Canafoglia L; Franceschetti S; Michelucci R; Markkinen S; Heron SE; Hildebrand MS; Andermann E; Andermann F; Gambardella A; Tinuper P; Licchetta L; Scheffer IE; Criscuolo C; Filla A; Ferlazzo E; Ahmad J; Ahmad A; Baykan B; Said E; Topcu M; Riguzzi P; King MD; Ozkara C; Andrade DM; Engelsen BA; Crespel A; Lindenau M; Lohmann E; Saletti V; Massano J; Privitera M; Espay AJ; Kauffmann B; Duchowny M; Møller RS; Straussberg R; Afawi Z; Ben-Zeev B; Samocha KE; Daly MJ; Petrou S; Lerche H; Palotie A; Lehesjoki AE
Nat Genet; 2015 Jan; 47(1):39-46. PubMed ID: 25401298
[TBL] [Abstract][Full Text] [Related]
8. Kv3.1 channelopathy: a novel loss-of-function variant and the mechanistic basis of its clinical phenotypes.
Li X; Zheng Y; Li S; Nair U; Sun C; Zhao C; Lu J; Zhang VW; Maljevic S; Petrou S; Lin J
Ann Transl Med; 2021 Sep; 9(18):1397. PubMed ID: 34733949
[TBL] [Abstract][Full Text] [Related]
9. Progressive myoclonic epilepsy: myoclonic epilepsy and ataxia due to KCNC1 mutation (MEAK): a case report and review of the literature.
Barot N; Margiotta M; Nei M; Skidmore C
Epileptic Disord; 2020 Oct; 22(5):654-658. PubMed ID: 32972906
[TBL] [Abstract][Full Text] [Related]
10. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK): a cause of progressive myoclonic epilepsy.
Mahale RR; Tiwari R; Arunachal G; Padmanabha H; Mailankody P
Acta Neurol Belg; 2022 Jun; 122(3):801-803. PubMed ID: 33725338
[No Abstract] [Full Text] [Related]
11. Loss of Function of KCNC1 is associated with intellectual disability without seizures.
Poirier K; Viot G; Lombardi L; Jauny C; Billuart P; Bienvenu T
Eur J Hum Genet; 2017 May; 25(5):560-564. PubMed ID: 28145425
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress-related cellular aging causes dysfunction of the Kv3.1/KCNC1 channel reverted by melatonin.
Spinelli S; Remigante A; Liuni R; Mantegna G; Legname G; Marino A; Morabito R; Dossena S
Aging Cell; 2024 May; ():e14185. PubMed ID: 38725150
[TBL] [Abstract][Full Text] [Related]
13. KCNC1-related disorders: new de novo variants expand the phenotypic spectrum.
Park J; Koko M; Hedrich UBS; Hermann A; Cremer K; Haberlandt E; Grimmel M; Alhaddad B; Beck-Woedl S; Harrer M; Karall D; Kingelhoefer L; Tzschach A; Matthies LC; Strom TM; Ringelstein EB; Sturm M; Engels H; Wolff M; Lerche H; Haack TB
Ann Clin Transl Neurol; 2019 Jul; 6(7):1319-1326. PubMed ID: 31353862
[TBL] [Abstract][Full Text] [Related]
14. Encephalopathies with KCNC1 variants: genotype-phenotype-functional correlations.
Cameron JM; Maljevic S; Nair U; Aung YH; Cogné B; Bézieau S; Blair E; Isidor B; Zweier C; Reis A; Koenig MK; Maarup T; Sarco D; Afenjar A; Huq AHMM; Kukolich M; Billette de Villemeur T; Nava C; Héron B; Petrou S; Berkovic SF
Ann Clin Transl Neurol; 2019 Jul; 6(7):1263-1272. PubMed ID: 31353855
[TBL] [Abstract][Full Text] [Related]
15. Impaired fast-spiking, suppressed cortical inhibition, and increased susceptibility to seizures in mice lacking Kv3.2 K+ channel proteins.
Lau D; Vega-Saenz de Miera EC; Contreras D; Ozaita A; Harvey M; Chow A; Noebels JL; Paylor R; Morgan JI; Leonard CS; Rudy B
J Neurosci; 2000 Dec; 20(24):9071-85. PubMed ID: 11124984
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of Kv3.1b and Kv3.2 potassium channel subunits in interneurons of the basolateral amygdala.
McDonald AJ; Mascagni F
Neuroscience; 2006; 138(2):537-47. PubMed ID: 16413129
[TBL] [Abstract][Full Text] [Related]
17. Rescue of motor coordination by Purkinje cell-targeted restoration of Kv3.3 channels in Kcnc3-null mice requires Kcnc1.
Hurlock EC; Bose M; Pierce G; Joho RH
J Neurosci; 2009 Dec; 29(50):15735-44. PubMed ID: 20016089
[TBL] [Abstract][Full Text] [Related]
18. K
Boddum K; Hougaard C; Xiao-Ying Lin J; von Schoubye NL; Jensen HS; Grunnet M; Jespersen T
Neuropharmacology; 2017 May; 118():102-112. PubMed ID: 28242439
[TBL] [Abstract][Full Text] [Related]
19. Opening the K
Gandini MA; Zamponi GW
Cell Rep Med; 2024 Feb; 5(2):101425. PubMed ID: 38382469
[TBL] [Abstract][Full Text] [Related]
20. A KCNC1 mutation in epilepsy of infancy with focal migrating seizures produces functional channels that fail to be regulated by PKC phosphorylation.
Zhang Y; Ali SR; Nabbout R; Barcia G; Kaczmarek LK
J Neurophysiol; 2021 Aug; 126(2):532-539. PubMed ID: 34232791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
